Myogenic differentiation pathway

The endogenous myogenic differentiation pathway is the fundamental biological process through which skeletal muscle tissue is formed, maintained, and repaired. This pathway involves the activation of resident muscle stem cells, known as satellite cells, which proliferate and differentiate into specialized muscle cells called myoblasts that eventually fuse to form mature, multinucleated myofibers. The process is tightly regulated by a cascade of transcription factors known as Myogenic Regulatory Factors (MRFs), including MyoD1, Myogenin, Myf5, and MRF4, which orchestrate the expression of genes essential for muscle structure and function. Additionally, extrinsic signaling pathways such as Notch, Wnt, and the TGF-beta/Myostatin axis play critical roles in modulating the balance between stem cell self-renewal and terminal differentiation. In pathological conditions like Duchenne Muscular Dystrophy (DMD) or age-related sarcopenia, this pathway is often dysfunctional or exhausted, leading to failed regeneration and progressive muscle loss. Therapeutic strategies aim to restore or enhance this pathway by targeting specific molecular brakes, such as Myostatin, or by modulating stem cell signaling and polarity via targets like AAK1 to promote effective muscle repair and functional recovery.

Other names

Myogenesis pathwaySkeletal muscle differentiation pathwayMuscle regeneration pathwayEndogenous myogenic differentiation program

Modulation of signaling cascades (e.g., Notch, Wnt, TGF-beta/Myostatin) and transcriptional regulators (e.g., MyoD, Myogenin) to promote the activation, proliferation, and terminal differentiation of muscle stem cells into functional myofibers.